Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Veletic I, Ferrajoli A, Burger J, O'Brien S, Bose P, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z.

Mol Cancer Res. 2017 May;15(5):610-618. doi: 10.1158/1541-7786.MCR-16-0291. Epub 2017 Jan 27.

PMID:
28130399
2.

Effective Combination Therapies for B-cell Lymphoma Predicted by a Virtual Disease Model.

Du W, Goldstein R, Jiang Y, Aly O, Cerchietti L, Melnick A, Elemento O.

Cancer Res. 2017 Apr 15;77(8):1818-1830. doi: 10.1158/0008-5472.CAN-16-0476. Epub 2017 Jan 27.

PMID:
28130226
3.

Structure of the Toll/Interleukin-1 Receptor (TIR) Domain of the B-cell Adaptor That Links Phosphoinositide Metabolism with the Negative Regulation of the Toll-like Receptor (TLR) Signalosome.

Halabi S, Sekine E, Verstak B, Gay NJ, Moncrieffe MC.

J Biol Chem. 2017 Jan 13;292(2):652-660. doi: 10.1074/jbc.M116.761528. Epub 2016 Dec 1.

4.

A respiratory chain controlled signal transduction cascade in the mitochondrial intermembrane space mediates hydrogen peroxide signaling.

Patterson HC, Gerbeth C, Thiru P, Vögtle NF, Knoll M, Shahsafaei A, Samocha KE, Huang CX, Harden MM, Song R, Chen C, Kao J, Shi J, Salmon W, Shaul YD, Stokes MP, Silva JC, Bell GW, MacArthur DG, Ruland J, Meisinger C, Lodish HF.

Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):E5679-88. doi: 10.1073/pnas.1517932112. Epub 2015 Oct 5. Erratum in: Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):E2094.

5.

The defect of SFRP2 modulates an influx of extracellular calcium in B lymphocytes.

Tokuda Y, Tanaka M, Yagi T, Tashiro K.

BMC Res Notes. 2014 Nov 4;7:780. doi: 10.1186/1756-0500-7-780.

6.

Does B cell receptor signaling in chronic lymphocytic leukaemia cells differ from that in other B cell types?

Slupsky JR.

Scientifica (Cairo). 2014;2014:208928. doi: 10.1155/2014/208928. Epub 2014 Jul 2. Review.

7.

Phosphoinositides: tiny lipids with giant impact on cell regulation.

Balla T.

Physiol Rev. 2013 Jul;93(3):1019-137. doi: 10.1152/physrev.00028.2012. Review.

8.

Novel Bruton's tyrosine kinase inhibitors currently in development.

D'Cruz OJ, Uckun FM.

Onco Targets Ther. 2013;6:161-76. doi: 10.2147/OTT.S33732. Epub 2013 Mar 6.

9.

Role of Src homology domain binding in signaling complexes assembled by the murid γ-herpesvirus M2 protein.

Pires de Miranda M, Lopes FB, McVey CE, Bustelo XR, Simas JP.

J Biol Chem. 2013 Feb 8;288(6):3858-70. doi: 10.1074/jbc.M112.439810. Epub 2012 Dec 20.

10.

Phospholipase Cγ2 plays a role in TCR signal transduction and T cell selection.

Fu G, Chen Y, Schuman J, Wang D, Wen R.

J Immunol. 2012 Sep 1;189(5):2326-32. doi: 10.4049/jimmunol.1103458. Epub 2012 Jul 25.

11.

Identification of Ser/Thr phosphorylation sites in the C2-domain of phospholipase C γ2 (PLCγ2) using TRPM7-kinase.

Deason-Towne F, Perraud AL, Schmitz C.

Cell Signal. 2012 Nov;24(11):2070-5. doi: 10.1016/j.cellsig.2012.06.015. Epub 2012 Jul 1.

12.

The role of SH3BP2 in the pathophysiology of cherubism.

Reichenberger EJ, Levine MA, Olsen BR, Papadaki ME, Lietman SA.

Orphanet J Rare Dis. 2012 May 24;7 Suppl 1:S5. doi: 10.1186/1750-1172-7-S1-S5. Epub 2012 May 24. Review.

13.

A novel regulatory mechanism links PLCγ1 to PDK1.

Raimondi C, Chikh A, Wheeler AP, Maffucci T, Falasca M.

J Cell Sci. 2012 Jul 1;125(Pt 13):3153-63. doi: 10.1242/jcs.100511. Epub 2012 Mar 27. Erratum in: J Cell Sci. 2017 Mar 1;130(5):1016.

14.

Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia.

Balakrishnan K, Gandhi V.

Expert Opin Investig Drugs. 2012 Apr;21(4):409-23. doi: 10.1517/13543784.2012.668526. Epub 2012 Mar 9. Review.

15.

The phospholipase C isozymes and their regulation.

Gresset A, Sondek J, Harden TK.

Subcell Biochem. 2012;58:61-94. doi: 10.1007/978-94-007-3012-0_3. Review.

16.

Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton's tyrosine kinase, Btk, inhibitor.

MacGlashan D Jr, Honigberg LA, Smith A, Buggy J, Schroeder JT.

Int Immunopharmacol. 2011 Apr;11(4):475-9. doi: 10.1016/j.intimp.2010.12.018. Epub 2011 Jan 14.

17.

Syk and pTyr'd: Signaling through the B cell antigen receptor.

Geahlen RL.

Biochim Biophys Acta. 2009 Jul;1793(7):1115-27. doi: 10.1016/j.bbamcr.2009.03.004. Epub 2009 Mar 21. Review.

18.

rac regulates its effector phospholipase Cgamma2 through interaction with a split pleckstrin homology domain.

Walliser C, Retlich M, Harris R, Everett KL, Josephs MB, Vatter P, Esposito D, Driscoll PC, Katan M, Gierschik P, Bunney TD.

J Biol Chem. 2008 Oct 31;283(44):30351-62. doi: 10.1074/jbc.M803316200. Epub 2008 Aug 26.

19.

Phospholipase C-gamma2 and Vav cooperate within signaling microclusters to propagate B cell spreading in response to membrane-bound antigen.

Weber M, Treanor B, Depoil D, Shinohara H, Harwood NE, Hikida M, Kurosaki T, Batista FD.

J Exp Med. 2008 Apr 14;205(4):853-68. doi: 10.1084/jem.20072619. Epub 2008 Mar 24. Erratum in: J Exp Med. 2008 May 12;205(5):1243.

20.

Synergistic activation of phospholipases Cgamma and Cbeta: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release.

Kuehn HS, Beaven MA, Ma HT, Kim MS, Metcalfe DD, Gilfillan AM.

Cell Signal. 2008 Apr;20(4):625-36. doi: 10.1016/j.cellsig.2007.11.016. Epub 2008 Jan 22.

Supplemental Content

Support Center